The wealthy entrepreneur: I want to support millions of employees!.

Chapter 945: Starting a pharmaceutical company, Romi Biotechnology! Good luck!

"I saw it bullying the neighbor's cat, so I slapped it off the wall!"

“This definitely sounds like something Xiaomi would do!” Tao Xue nodded. “Xiaomi is like a little tiger; it even bullies dogs… I guess only the big orange cat could be its match?”

"You're even bullying the dog?"

"I've seen those medium-sized ones before!"

"oh oh!"

After arriving at the company, around 10 a.m., Su Yang's phone was dialed.

Seeing that the message was labeled "Xu Cheng, Chairman of Chengshi Pharmaceuticals", he answered the phone.

"Hello, Ms. Su!"

"Hello, Mr. Xu, is there something you need?" Su Yang asked curiously. "Is there a problem with the private equity fund?"

Xu Cheng was introduced to him by Han Kun. He was both a shareholder of Han Kun Baihua Pharmaceutical and the chairman of Hunan Chengshi Pharmaceutical.

This is a non-listed company. Its net worth is not as high as Han Kun's, but it is still quite powerful. The two met in Shancheng last time. It is considered a potential client of Yuanshi Private Equity. Su Yang does not know whether he has made a purchase or not!

"It's not about private equity!" Xu Cheng said awkwardly. "Didn't President Su say he was interested in innovative drugs? I invested in an innovative drug company before, and now that company is short of funds. I was wondering if you would be interested?"

He recalled for a moment, and realized that he had indeed said such a thing to Xu Cheng!

The main reason is that many of the wealthy people he met in the mountain city at that time were involved in pharmaceutical companies or related industries!

He'll naturally chime in with his thoughts on what the client likes to hear and what interests them.

Moreover, he does have a good habit of casting a wide net, always hoping that these rich people will sell him some assets at a low price!

But is this guy trying to get me to take over his business?

Although Su Yang harbored such doubts, he still feigned interest and asked:

"What company? What do they do?"

"They're developing innovative anti-cancer drugs, have gone through three rounds of financing, have very solid technology, and an outstanding team!"

"Ok!"

Su Yang has reservations about Xu Cheng's assessment.

Over the years, many people have approached him to solicit investment, and the vast majority of them have made exaggerated claims. However, after careful investigation, Su Yang was greatly disappointed and felt that it would be better to do it himself!

"what company?"

"Luomi Biotechnology!"

Su Yang casually typed "Luomi Biotechnology" into his computer and found relevant information on the official website.

It does appear to be an innovative drug company, having gone through three rounds of financing, raising a total of over $200 million. However, its official website is poorly maintained and looks somewhat dilapidated!

He wasn't exactly an outsider when it came to investing in and developing innovative drugs; he had at least some knowledge of it.

This industry is very risky, often requiring several years or even more than a decade of research and development time, and investments of hundreds of millions, billions, or even tens of billions... Sometimes, investing 20 billion might not even result in seeing a product, making it almost as unreliable as some new energy vehicle companies.

This has led to many investors turning innovative drug companies into a relay game. One investor invests for a period of time, achieves certain results, and then sells the shares to the next investor, or lets the company raise more money to invest in research and development.

After all, many investors can't withstand this kind of financial pressure!

Seeing that Su Yang did not speak, Xu Cheng continued:

"I trust this company, but my company is currently facing some financial difficulties and needs to turn over some cash. Mr. Su, would you be interested?"

"Ok!"

Sure enough, they came looking for him to take over their business!

Xu Cheng's reason for asking Su Yang to take over was simple: he knew that Su Yang was involved in pharmaceutical companies, even in animal drugs, and he also "knew" that Su Yang was interested in innovative drugs.

Most importantly, he knew Su Yang was extremely wealthy. He had roughly investigated Jufan Holdings and it seemed they wanted to get involved in everything, constantly making acquisitions over the years!
These days, there aren't many people like Su Yang who have ample cash flow and dare to invest and expand!
Most importantly, Su Yang is still running a professional football club!
He asked the other shareholders of RomiBio, but because Pumi is not doing well, none of these shareholders and investors have any intention of taking over!
Su Yang looked at the official information about Romi Biotechnology, did a little business analysis, and then couldn't help but laugh... What can I say about this company?

Something!

About six months later, due to a lack of research and development funds, the company will be forced to sell its unfinished bispecific anti-tumor drug to a Swiss company, Acer Pharmaceuticals, for $1.2 billion.

Aisi Pharmaceuticals has acquired the global (excluding Greater China) rights to develop, manufacture and commercialize the drug.

Around the end of next year, Aisi Pharmaceuticals will acquire Romi Bio for one billion US dollars.

Having acquired all of RomiBio's technology patents, ongoing R&D projects, and the company's talent pool, RomiBio has now become Aisi Pharma's R&D subsidiary!

Su Yang was certain that this company was highly capable.

Otherwise, it wouldn't have been acquired by a pharmaceutical giant at a high price.

Even without selling the company, the $1.2 billion in revenue from selling the semi-finished drugs alone is enough to make Su Yang take action!

After all, this is US dollars!

$1.2 billion is at least over 8 billion RMB!
Indeed, casting a wide net and building extensive connections and good relationships was the right thing to do!

He suppressed a smile and said in a calm tone, "Tell me more about this company!"

"Ok!"

Upon discovering that Su Yang was genuinely interested, Xu Cheng launched into a long and detailed explanation of RomiBio.

It's clear that Xu Cheng is quite professional. He himself is a medical school graduate, and he didn't use any technical jargon when explaining things to Su Yang, so even Su Yang, who is only a layman, could understand!

"How are you feeling, Mr. Su?"

Then Su Yang heard the sound of someone drinking water on the other side.

"feel good!"

"If Su Yang is interested, I can come to Rongcheng tomorrow, and I can even take you to see the company!"

How many shares do you own, and how many are you planning to sell?

“I think the company can be valued at six hundred million US dollars. I have 5% of the shares, and I can sell them to President Su for two hundred million dollars at a cheaper price!”

Hearing that the valuation was already six hundred million US dollars, Su Yang frowned slightly.

He knew that bargains weren't so easy to come by, meaning that buying the entire company would require more than four billion!

However, the thought of the nearly 10 billion yuan in funds within Yuanshi Wealth No. 1 gave him confidence.

He's been keeping a large sum of money untouched, waiting for the right opportunity.

Now, he believes that RomiBio is a rare opportunity!
Besides, he definitely won't pay in one lump sum this time!
In investing, if you're lucky enough to find a good company and catch the right trend, you can live off it for a lifetime!

For example, SoftBank's Masayoshi Son, who invested in Alibaba, has been losing money on his other investments since his successful investment in Alibaba!
But they have the capital to lose money.

Because they made $720 billion from Alibaba, which is more than 4500 billion RMB!

As an innovative drug company, RomiBio certainly doesn't have many employees; it might not even have two hundred.

Under normal circumstances, he would definitely prefer companies with a large number of employees.

However, if it can bring Su Yang enough substantial benefits, then it is still worth making a move!
He's not happy about such a good company being acquired by a foreign company!

Moreover, the drug can sell for $1.2 billion even before it's fully developed. How much would it sell for once it's fully developed?

According to its official website, RomiBio has more than one research and development project!
Maybe there will be a surprise?
It's normal for a successful innovative drug to earn tens of billions of dollars!
This industry is all about high risk and high reward!
It's worth noting that Aisi only acquired RomiBio ten months later, which means that subsequent drug development must have gone very smoothly!
Despite his inner joy, Su Yang remained composed and asked, "How long ago was that valuation? Was the fundraising a failure back then?"

"Uh... how did President Su know?"

"I found it online!" Su Yang said with a smile after clicking the mouse a few times. "The fourth round of financing failed, and they can't find anyone to take over. Their R&D funds are quite tight, and the company might go bankrupt any day!"

(End of this chapter)